TNFRSF9 and cancer: FAP-4-1BBL is a bispecific costimulator targeting the Fibroblast Activation Protein (FAP) expressed in cancer-associated fibroblasts, and the 4-1BB (CD137) receptor, which is expressed in activated T cells (Claus et al., 2019).